Discussion
DSEK and DMEK are considered the procedures of choice in cases of endothelial dysfunctions. [1] Both intraoperative and postoperative complications do occur in DSEK and one among them is graft failure. [2] The repeat DSEK procedure can be easily performed in most of the failed cases with satisfactory results. DMEK is also considered as a feasible choice in patients with graft failure after DSEK. [3] Few reports suggest that results after DMEK as a procedure to treat graft failure after DSEK were as good as in patients that underwent DMEK. [4] Goh et al. reported a similar case of repeat DSEK done on a failed DSEK without removing it. [5] In our case, we treated the failed DSEK graft with a DMEK graft without removing it, and postoperatively the graft attached well with clearing of corneal edema and DSEK graft edema.
To our knowledge, this case is unique that a DMEK on a retained DSEK was performed without removing the failed DSEK. Here, we demonstrate a case where the above was performed with a successful visual and overall outcome indicating that this option can be clinically considered.
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Case Report
A 30-year-old lady of diagnosed von Hippel-Lindau (VHL) disease was referred to us for ophthalmological evaluation. Her visual acuity was 6/6 in both eyes and anterior segment examination was normal. On fundus examination, bilateral multiple retinal capillary hemangioblastomas (RCH) were seen within and around the inferior retinochoroidal colobomas [Figs. [1] [2] [3] [4] . Multiple feeder arteries and tortuous, beaded draining veins were seen. Fundus fluorescein angiography showed leakage [ Fig. 5 ]. One sitting of barrage laser was done around the coloboma. Patient did not consent to further treatment as there was no ocular symptom. At 1 year of follow-up although slight increase in size of some tumors were noted, visual acuity remained stable and no complications were seen.
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Discussion
VHL disease is an autosomal dominant disorder characterized by tumors and cysts in multiple organs due to mutation in VHL tumor suppressor gene on chromosome 3. RCH is one of the most frequent presenting feature of the disease occurring in 49% to 85% cases. [1] Retinochoroidal coloboma is a rare eye malformation, can be sporadic or inherited, frequently with mutation in PAX2 gene, and is known to be part of various genetic syndromes. Association of retinochoroidal coloboma with VHL disease or RCH with coloboma in VHL disease has never been reported.
Capillary hemangioblastoma can cause vision loss from exudation, haemorrhage, and retinal detachment. The most common complication associated with retinochoroidal colobomas is retinal detachment, occurring in 8.1-43% of cases. [2, 3] Presence of both entities, as in our case, can increase the risk by several folds.
Lasave and Deromedis reported bilateral chorioretinal coloboma and a solitary, unilateral RCH and suggested a possible correlation between ischemic areas of the coloboma and production of vascular endothelial growth factor leading to abnormal vessel growth in the form of retinal hemangioblastomas. [4] In our case, bilateral aggregation of the retinal hemangioblastomas over and around the coloboma adds to the above hypothesis that some factors like ultrastructural abnormality of the colobomatous area or ischemia definitely play a role in this association rather than being a mere coincidence. Further genetic studies will help to establish the possible syndromic association between these two entities.
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